Organization
Baptist Health South Florida
15 clinical trials
56 abstracts
Abstract
Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial.Org: Department of Neurosurgery, Prince of Wales Hospital, Department of Radiation Oncology, Baptist Health South Florida, Perelman School of Medicine, Department of Radiology,
Abstract
Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), safety and efficacy in a broad distribution of FolRα expression in patients with recurrent epithelial ovarian cancer (OC): Update of STRO-002-GM1 phase 1 dose expansion cohort.Org: Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, The Ohio State University James Cancer Center, Sidney Kimmel Cancer Center at Thomas Jefferson University, University of Chicago,
Abstract
Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study.Org: Miami Cancer Institute, Poznan University of Medical Sciences, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, General University Hospital in Prague,
Abstract
Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.Org: Miami Cancer Institute, Baptist Health South Florida, Northwestern Medicine Cancer Center Warrenville, Northwestern Medicine Proton Center, CHUM,
Abstract
Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003.Org: Sharei Zedek Hospital, NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, PA, Northwestern Medicine Cancer Center Warrenville, Northwestern Medicine Proton Center, Baptist Health South Florida,
Abstract
Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan.Org: Miami Cancer Institute, Baptist Health South Florida, Guardian Research Network,
Abstract
Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC): Updated data and subgroup analyses by age, sites of disease, and use of intervening therapies.Org: University of California, San Francisco, Miami Cancer Institute, Baptist Health South Florida, Mayo Clinic, Rush University Medical Center,
Abstract
An open-label, multicenter, phase 2 study to evaluate the safety and efficacy of BB-1701, a novel antibody drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), in previously treated patients with HER2-positive (HER2+) or HER2-low unresectable or metastatic breast cancer (BC).Org: UCLA Health Jonsson Comprehensive Cancer Center, Los Angeles, CA, Mayo Clinic, Miami Cancer Institute, Baptist Health South Florida, NW Medical Specialties,
Abstract
Impact of race and ethnicity on financial toxicity in patients with genitourinary cancers.Org: Corewell Health System - Beaumont University Hospital, William Beaumont University Hospital, Royal Oak, MI, Miami Cancer Institute, Baptist Health South Florida,
Abstract
Trend and burden of cancer related hospitalizations in the US: Insights from a National Inpatient Sample Database analysis.Org: University of Vermont Medical Center, Roswell Park Comprehensive Cancer Center, University of California, Riverside, Corewell Health William Beaumont University Hospital, Miami Cancer Institute,
Abstract
Activating HR+/HER2- and triple-negative breast cancer care teams and their patients in shared decision-making.Org: PRIME Education, LLC, Miami Cancer Institute, Baptist Health South Florida,
Abstract
Dual-agent immunotherapy for prevention of melanoma brain metastases: A real-world analysis of 8686 patients.Org: Penn State Milton S. Hershey Medical Center, Hershey, PA, Penn State College of Medicine, University Park, PA, University of Toronto,
Abstract
Barriers to accrual and enrollment in brain tumor trials.Org: Dana-Farber Cancer Institute, Massachusetts General Hospital, University of California Irvine, The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center School of Nursing,
Abstract
Development of clinically accessible nomograms to predict risk of brain metastases at baseline and follow-up in patients with non-small cell lung cancer.Org: Penn State College of Medicine, University of Toronto, John Hopkins University, Arizona College of Osteopathic Medicine, Penn State Hershey Medical Center,
Abstract
A phase II, open label, single arm study of nivolumab for recurrent or progressive IDH mutant gliomas with prior exposure to alkylating agents.Org: Columbia University Irving Medical Center, New York, NY, USA, Dana-Farber Cancer Institute, Miami Cancer Institute, Baptist Health South Florida, Rhode Island Hospital,
Abstract
A randomized, controlled, phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent glioblastoma (NAVAL).Org: Miami Cancer Institute, Baptist Health South Florida, Cleveland Clinic Lerner College of Medicine, Department of Internal Medicine, William Beaumont University Hospital, The University of North Carolina at Chapel Hill,
Abstract
Unraveling the immunologic vulnerabilities of diffuse hemispheric glioma, H3 G34-mutant.Org: University of Minnesota, Caris Life Sciences, Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Miami Cancer Institute,
Clinical trial
A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive MeningiomaStatus: Recruiting, Estimated PCD: 2025-11-01
Abstract
Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.Org: Yale Cancer Center, Yale School of Medicine, Emory University School of Medicine, Nashville Breast Center, Dallas Surgical Group,
Clinical trial
Phase I Dose Escalation of T-cell Receptor α/β Depleted Donor Lymphocyte Infusions Following CD34+- Selected Allogeneic Stem Cell Transplantation From Related & Unrelated Donors in Patients With Lymphoid, Myeloid or Plasma Cell MalignanciesStatus: Active (not recruiting), Estimated PCD: 2026-04-01
Clinical trial
Evaluating Immune Checkpoint Inhibition In Solid Tumor Patients With Homologous Recombination Repair DeficiencyStatus: Completed, Estimated PCD: 2020-10-20
Abstract
A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION).Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Landscape analysis and oncologic outcomes in advanced urothelial carcinoma (UC) by NECTIN4 RNA expression.Org: University of California, San Diego, Moores Cancer Center, La Jolla, CA, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Caris Life Sciences, Irving, TX, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Dissecting the significance of ACP1 gene alterations in prostate cancer (PCa).Org: Cleveland Clinc, Caris Life Sciences, Irving, TX, Caris life sciences and the University of South Carolina, Huntsman Cancer Institute, Miami Cancer Institute - Baptist Health South Florida,
Abstract
Targeted interventions to address local challenges in HR+/HER2- and HER2+ breast cancer treatment in community-based settings.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Sarah Cannon Research Institute/Tennessee Oncology, PRIME Education, LLC,
Abstract
Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, William Beaumont University Hospital,
Abstract
A retrospective, descriptive analysis of a single-center experience with patients with metaplastic breast cancer.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Racial and ethnic disparities in hospital outcomes following hospitalizations for mastectomy for breast cancer.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL,
Abstract
Survival outcomes associated with treatment modalities in stage 4 gallbladder neuroendocrine tumors: A nationwide analysis.Org: Wyckoff Heights Medical Center, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, King Edward Medical University, Shalamar Hospital,
Abstract
Impact of delirium on in-patient outcomes in patients with pancreatic cancer: A nationwide study.Org: Wyckoff Heights Medical Center, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Cancer screening in sexual and gender minority populations: A systematic review and meta-analysis.Org: Corewell Health William Beaumont University Hospital, Royal Oak, MI, Roswell Park Comprehensive Cancer Center, Buffalo, NY, University of Vermont Medical Center,
Abstract
CSF proteomics for predicting response to treatment in patients with primary and secondary central nervous system lymphoma.Org: Penn State College of Medicine, University Park, PA, PainReform, University of Toronto, Toronto Allergy and Asthma Centre,
Abstract
Survival outcomes in patients with advanced intrahepatic cholangiocarcinoma in United States: A nationwide analysis.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Wyckoff Heights Medical Center, Mayo Hospital, King Edward Medical University,
Abstract
Clustering analysis for predicting racial disparities in genitourinary cancer–related financial burden.Org: Baptist Health South Florida, Corewell Health William Beaumont University Hospital, CK-12 Foundation, Miami Cancer Institute - Baptist Health South Florida, Stanford University School of Medicine,
Abstract
Impact of treatment approaches in patients with advance penile cancer: An analysis from a nationwide study.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, William Beaumont University Hospital, Royal Oak, MI,
Abstract
Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Flare Therapeutics, St. John's Medical College, Bangalore, India, Bangalore Medical College And Research Institute,
Abstract
Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL, John Hopkins University, Baltimore, MD,
Abstract
Effect of heart failure on mortality and clinical outcomes in patients hospitalized with pancreatic cancer.Org: Wyckoff Heights Medical Center, Brooklyn, NY, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL,
Clinical trial
Phase II Trial of In Situ Tumor Vaccination Using Durvalumab and "Booster" Radiation Therapy in Patients With Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Through First-line ChemotherapyStatus: Terminated, Estimated PCD: 2020-07-09
Clinical trial
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery (FACILITATE)Status: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease (PROMISSeD Trial)Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
A Non-Myeloablative Conditioning Regimen With Peri-Transplant Rituximab and the Transplantation of Hematopoietic Stem Cells From HLA-compatible Related or Unrelated Donors in Patients With B-Cell Lymphoid MalignanciesStatus: Withdrawn, Estimated PCD: 2026-03-01
Clinical trial
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain MetastasisStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Characterization of Large Brain Metastases With 18F-Fluciclovine PET/CT Treated With Staged Stereotactic RadiosurgeryStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Randomized Controlled Trial of ZYNRELEF Versus Standard of Care for Pain Management Following Unilateral Total Knee ArthroplastyStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Zanubrutinib With Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial With a Safety Lead-InStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
Phase 1 Trial of Tucatinib, Trastuzumab, and Capecitabine With Stereotactic Radiosurgery (SRS) in Patients With Brain Metastases From HER-2 Positive Breast CancerStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Cemiplimab/PEG-Interferon-α Combination for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)Status: Withdrawn, Estimated PCD: 2026-07-01
Clinical trial
A Phase I/II Trial of Combination Tumor Treating Fields, Nivolumab Plus/Minus Ipilimumab for Recurrent GlioblastomaStatus: Terminated, Estimated PCD: 2020-05-29
Clinical trial
A Phase I/II Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain MetastasesStatus: Recruiting, Estimated PCD: 2025-10-01
Abstract
Investigation of leptomeningeal disease in high grade glioma and characterization of molecular alterations.Org: Caris Life Sciences, Irving, TX, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Levine Cancer Institute,
Abstract
Phase I study of BTK inhibitor ibrutinib with temozolomide and radiation in newly-diagnosed glioblastoma (EQUILIBRIUM): Final trial report.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Cleveland Clinic Taussig Cancer Instititute, Cleveland Clinic Foundation, Cleveland Clinic Brunswick Urgent Care,
Abstract
Pan-cancer associations of B7-H3 (CD276) transcriptional expression across human malignancies.Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, Caris Life Sciences, Irving, TX, Puerto Rico Medical Research Center, Barbara Ann Karmanos Cancer Institute, Huntsman Cancer Institute (NCI-CCC),
Abstract
Surgically targeted radiation therapy (STaRT) for recurrent glioblastoma: Initial outcomes from a prospective multicenter registry.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, GT Medical Technologies, University of Minnesota Medical Center, University of Texas Southwestern Medical Center,
Abstract
Safety and feasibility of JAK inhibitor ruxolitinib in newly-diagnosed high-grade gliomas (CRUX): Final toxicity report.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Cleveland Clinic Brunswick Urgent Care, Cleveland Clinic Foundation, Cleveland Clinic Taussig Cancer Instititute,
Abstract
Low-intensity focused ultrasound with systemic microbubble oscillators for blood-brain barrier disruption for liquid biopsy in glioblastoma (LIBERATE).Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami Neuroscience Institute, Mayo Clinic, University of California Irvine,
Abstract
Evaluating the diagnostic performance of leptomeningeal diagnosis with CNSide compared to standard cytology.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Vanderbilt University Medical Center,
Abstract
FOXC1 expression in meningiomas.Org: Nationwide Children’s Hospital, Caris Life Sciences, Irving, TX, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA, Miami Cancer Institute - Baptist Health South Florida,
Abstract
Clinical outcomes of immune checkpoint inhibitor treatment in patients with classic cold tumors identified to have a high tumor mutational burden via ctDNA.Org: Guardant Health, Inc., Mayo Clinic Florida, Mayo Clinic, Emory University, Atlanta, GA, USA, Miami Cancer Institute - Baptist Health South Florida,
Abstract
Survival outcomes of sarcomatoid versus classic urothelial carcinoma of bladder.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Florida International University, Herbert Wertheim College of Medicine,
Abstract
Survival outcomes of micropapillary versus classic variant, loco-regional bladder cancer: A 2004-2019 National Cancer Database analysis.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Participation in phase I oncology trials by minorities: Survival and compliance data.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL,
Abstract
Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: Single institution retrospective study.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non–small-cell lung cancer.Org: Lung Cancer Research, Sarah Cannon Research Institute/Tennessee Oncology, Tennessee Oncology, PLLC, Sarah Cannon Research Institute at HealthONE, Next Oncology Virginia and Virginia Cancer Specialists,
Abstract
Enhancing lung cancer screening through ‘Saved by the Scan’: Lessons from a multipronged public service advertising program.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Miami, FL, 8900 N Kendall Dr, Flare Therapeutics,
Abstract
Characterizing imposter syndrome among oncologists on social media.Org: Valley Health System, Paramus, NJ, Medical College of Wisconsin, Milwaukee, WI, Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI,
Abstract
Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Flare Therapeutics, Plantation, Guardant Health, Inc.,
Abstract
Differential efficacy of antidepressants in the treatment of hormone mediated depression in patients with ER+ breast cancer.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Prophylactic cranial irradiation in small cell lung cancer patients in the era of magnetic resonance imaging: A systematic review and meta-analysis.Org: University of Toronto, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Princess Margaret Cancer Centre, University Health Network,
Abstract
Authorship diversity in global evidence synthesis in genitourinary oncology: A 1998-2022 analysis of Cochrane Reviews.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, King George's Medical University, Florida International University, Herbert Wertheim College of Medicine,
Abstract
Ethnic disparities in biomarker testing and targeted therapy use in metastatic lung adenocarcinoma: A 2014-2021 analysis.Org: Florida International University, Herbert Wertheim College of Medicine, Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Guardian Research Network,